Indian Journal of PsychiatryIndian Journal of Psychiatry
Home | About us | Current Issue | Archives | Ahead of Print | Submission | Instructions | Subscribe | Advertise | Contact | Login 
    Users online: 246 Small font sizeDefault font sizeIncrease font size Print this article Email this article Bookmark this page


    Advanced search

    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Email Alert *
    Add to My List *
* Registration required (free)  

    Materials and Me...
    Article Tables

 Article Access Statistics
    PDF Downloaded631    
    Comments [Add]    
    Cited by others 23    

Recommend this journal


ORIGINAL ARTICLE Table of Contents   
Year : 2008  |  Volume : 50  |  Issue : 1  |  Page : 16-20
Evaluation of antioxidant deficit in schizophrenia

1 Department of Biochemistry, SMS Medical College and Hospital, Jaipur, Rajasthan, India
2 Department of Psychiatry, SMS Medical College and Hospital, Jaipur, Rajasthan, India

Click here for correspondence address and email


Aim: Oxidative stress is a state in which there is disequilibrium between pro-oxidant processes and the antioxidant defense system in favor of the former and occurs as a consequence of increased production of free radicals or when the antioxidant defense system is inefficient or a combination of both events. A disturbance in the antioxidant defense system, including antioxidant enzymes superoxide dismutase (SOD) and glutathione peroxidase (GSHPx), due to free radical-induced oxidative injury has also been implicated in various neuropsychiatric disorders. Hence the role of these antioxidant enzymes and the changes in their level in blood and correlation with oxidative stress and the overall mechanism of defense were studied in a common psychiatric illness, schizophrenia.
Materials and Methods: Fifty subjects of either sex ranging in age from 18 to 60 years, divided into two age groups (<40 years and >40 years), diagnosed for schizophrenia; and 50 age- and sex-matched normal subjects as controls were included in the study. Blood samples were collected for the determination of malondialdehyde (MDA), superoxide dismutase (SOD), glutathione peroxidase (GSHPx), and reduced glutathione (GSH).
Results: Significantly lower levels of the two antioxidant enzymes were found in schizophrenics compared to normal controls, with an increased oxidative stress as indicated by high blood MDA levels. The condition worsened with advancing age, smoking, among literate masses, and in chronic schizophrenics; whereas gender did not show any effect.
Conclusion: It can be concluded that an imbalance in the antioxidant defense system, along with enzymatic antioxidants, occurs in schizophrenia due to the persistent oxidative stress. Modern life style perhaps also contributes to the condition.

Keywords: Antioxidant enzymes, GSHPx, MDA, oxidative stress, schizophrenia, SOD

How to cite this article:
Dadheech G, Mishra S, Gautam S, Sharma P. Evaluation of antioxidant deficit in schizophrenia. Indian J Psychiatry 2008;50:16-20

How to cite this URL:
Dadheech G, Mishra S, Gautam S, Sharma P. Evaluation of antioxidant deficit in schizophrenia. Indian J Psychiatry [serial online] 2008 [cited 2021 Oct 21];50:16-20. Available from:

   Introduction Top

Free radicals are species normally produced during cellular metabolism in aerobic cells, containing one or more unpaired electrons, highly reactive and can combine with a great variety of biomolecules, changing their physicochemical characteristics. [1] The brain tissues contain large amounts of polyunsaturated fatty acids and catecholamines, which are thought to be target molecules for free radical-induced peroxidation and neural cell damage. [2],[3] One of the end products of this self-perpetuating lipid peroxidation reaction includes the cytotoxic aldehyde; and malondialdehyde (MDA), which is considered a specific and sensitive measure of lipid auto-oxidation. In conditions of increased production or decreased scavenging of free radicals, an imbalance towards a pro-oxidant state is formed, which may also assume fundamental importance in the pathogenesis of acute or chronic brain diseases [4] like Parkinson's, tardive dyskinesia, schizophrenia. [5],[6] Schizophrenia is a common psychiatric disorder, marked by gross distortion from reality; disturbances in thinking, feeling, and behavior [7] ; and it is believed that increased oxidative stress [8] may be relevant to the pathophysiology of schizophrenia. [9]

The potential toxicity of free radicals is counteracted by a number of cytoprotective enzymes and antioxidants that limit the damage. [10],[11] This protective mechanism functions cooperatively in the form of a cascade in which the various cytoprotective enzymes such as superoxide dismutase (SOD) and glutathione peroxidase (GSHPx); and nutrient, as well as endogenous, antioxidants act in combination. [12],[13] In our previous studies, it has been found that the levels of nutrient antioxidants ascorbic acid [14] and α-tocopherol [15] decline as a result of the increasing oxidative stress in schizophrenia. Thus, the present study examines oxidative stress and the activities of antioxidant enzymes SOD and GSHPx, GSH; and the overall mechanism that is disturbed due to the growing oxidative stress. The effects of age, gender, nature of illness, life-style stresses, and smoking on the activities of antioxidants in schizophrenics have also been observed.

   Materials and Methods Top

The study was performed on 50 schizophrenic patients of either sex (39 males and 11 females) ranging in age from 18 to 60 years and divided into two groups: young subjects (<40 years, n = 25) and elderly subjects (>40 years, n = 25). All the subjects were thoroughly screened and diagnosed for schizophrenia at the OPD of Psychiatric Center, SMS Medical College, by one of the authors using the ICD-10 diagnosis criterion. A complete clinical and personal history of the subjects was recorded and consent to participate in the study was taken. Subjects with education up to 10 th standard were considered literates. The smokers were taking 10 or more cigarettes per day, and nonsmokers were absolutely free from the habit [Table - 1]. Psychological evaluation of each subject was done using Positive and Negative Syndrome Scale (PANSS). Subjects were selected using the following exclusion criterion:

  • Pregnant and lactating females
  • Symptoms of any other illness
  • History of receiving ECT in the last one year
  • Any substance dependence for the last one month
  • History or present symptoms of any other psychiatric disorder

These were compared with 50 age- and sex-matched normal healthy individuals belonging to the general population and marked as controls. Whole blood samples were drawn from the anticubital vein using aseptic technique. RBCs were separated for estimating malondialdehyde (MDA), an indicator of oxidative stress, [16] measuring it as a secondary fragmentation product of PUFA peroxide, a thiobarbituric acid-reactive substance (TBARS) that gives a pink color complex with thiobarbituric acid (TBA). It was read on a spectrophotometer at 535 nm wavelength. Hemolysate (1:20) was prepared to estimate SOD and GSHPx levels. SOD activity was measured by Randox kit method, using the ability to inhibit the generation of superoxide radicals formed by xanthine and xanthine oxidase activity and reading the degree of inhibition at 505 nm. GSHPx was assayed by measuring the rate of reduction of oxidized glutathione at 340 nm. [17] Reduced glutathione was assayed by reading the reduction of DTNB, forming yellow anion at 412 nm. [18]

Statistical analysis

Results were statistically explained by Students t-test, and correlation coefficient (r) was done between SOD, GSHPx, GSH, and MDA.

   Results Top

The results of this study indicate an impaired activity of major intracellular antioxidant enzymes SOD and GSHPx due to increased oxidative stress inherent in schizophrenia. The level of MDA, an indicator of oxidative stress and an end product of lipid peroxidation, measured as thiobarbituric acid-reactive substance (TBARS), was significantly ( P < 0.001) higher in schizophrenics, indicating increase in level of oxidative stress due to schizophrenia. [9] The SOD and GSHPx activities in red cells, which act as sinks for O 2 .- and H 2 O 2 produced in plasma, decreased significantly ( P < 0.001) in schizophrenics as compared to controls [Table - 2]. A significant ( P < 0.001) reduction in the level of reduced glutathione with increasing oxidative stress [Table - 2] was also observed.

An imbalance between oxidative stress and antioxidants in favor of oxidative stress was observed in schizophrenics in the present study [Table - 3], showing that lipid peroxidation is fundamental in the aging process. [22] However, no significant difference could be observed in oxidative stress and antioxidants when compared between males and females [Table - 4].

The study also examined if there is any contribution of risk factors related to habits or if these factors are associated with oxidative stress. Literates both in controls and schizophrenics were found to be at greater risk as they had significantly higher MDA level as compared to illiterates [Table - 5],[Table - 6]. A strong negative correlation was found between MDA, a measure of oxidative stress, and SOD (r = -0.88); between MDA and GSHPx (r = -0.87); and between MDA and GSH (r = -0.81) [Table - 7].

   Discussion Top

The increase in oxidative stress in the study seems to be a result of the toxic effects of free radicals, as they cause membrane defects, oxidation of the lipid membranes and also increase the rate of catecholamine oxidative metabolism, [5] all of which may play an important role in the pathophysiology of schizophrenia. [19] Further, the condition worsens due to advancing age, smoking, and in literates with a modern stressful life style and chronic stage of illness.

The modern stressful living, especially in the literate subjects, and self-pollution in the form of smoking have worsened the situation, thus contributing to oxidative stress. This can be attributed to the disturbance in the overall mechanism of generation of free radicals and their consequent neutralization due to oxidative stress in schizophrenia, where SOD is utilized for neutralizing the free radical superoxide ion (O 2 .- ) to H 2 O 2 and oxygen, and GSHPx reduces this H2 O2 to water. [20] Schizophrenia also seems to disturb the glutathione homeostasis, which is also one of the factors responsible for weakening the antioxidant defense provided by enzymatic antioxidants. [3],[21]

Age seems to have a definite impact on lipid peroxidation in the presence of antioxidant deficit. This imbalance in the antioxidant enzyme levels may be attributed as a resistance against the developing stress because the antioxidant enzymes are the first line of defense. [23]

The disturbance of the oxidant-antioxidant equilibrium now becomes quite evident in schizophrenia owing to the abnormal activity of the critical enzymes SOD and GSHPx. Depleted antioxidant status due to increased utilization with increasing oxidative stress has been reported. [9],[23],[24] However, few studies have advocated strengthening of antioxidant status in schizophrenia so as to counteract oxidative stress. [25],[26],[27] This difference in observation may probably be attributed to varied clinical symptoms or therapeutic features or duration of the illness. In the present study, all the participant schizophrenics had never taken any treatment earlier and had come for consultation for the first time.

Thus, a disturbance in the activities of antioxidant enzymes occurs in schizophrenia due to the increased oxidative stress, which further intensifies with the aging process and chronic stage of the illness. The gift of modern world, a stressful life; and a polluted environment also take their toll and deteriorate the condition of the schizophrenics. This also emphasizes the importance of nutrient antioxidant supplementation to support the entire antioxidant defense system.

   References Top

1.Marzatico F, Cafι C. Oxygen radicals and other toxic oxygen metabolites as key mediators of the central nervous system tissue injury. Funct Neurol 1993;8:51-66.  Back to cited text no. 1    
2.Ogawa N. Free radicals and neural cell damage. Rinsho Shinkeigaku 1994;34:1266-8.  Back to cited text no. 2  [PUBMED]  
3.Bandopadhyay D, Das D, Banerjee RK. Reactive oxygen species: Oxidative damage and pathogenesis. Curr Sci 1999;77:658-66.  Back to cited text no. 3    
4.Stohs SJ. The role of free radicals in toxicity and disease. J Basic Physiol Pharmacol 1995;6:205-28.  Back to cited text no. 4    
5.Lohr JB. Oxygen radicals and neuropsychiatric illnesses. Arch Gen Psychiatry 1991;48:1097-106.  Back to cited text no. 5  [PUBMED]  
6.Mahadik SP, Scheffer RE. Oxidative injury and potential use of antioxidants in schizophrenia. Prostaglandins Leukocyte Essential Fatty Acids 1996;55:45-54.  Back to cited text no. 6    
7.Kaplan HI, Sadock BJ. Comprehensive Textbook of Psychiatry. 6 th ed, Vol.1, 1989. p. 699-776.  Back to cited text no. 7    
8.Davies KJ. Oxidative stress: The paradox of aerobic life. Biochem Soc Symp 1995;61:1-31.  Back to cited text no. 8    
9.Akyol O, Herken H, Uz E, Fadillioglu E, Unal S, Sogut S, et al . The indices of oxidative and antioxidative processes in plasma from schizophrenic patients: The possible role of oxidant/antioxidant imbalance. Prog Neuropsychopharmacol Biol Psychiatry 2002;26:995-1005.  Back to cited text no. 9    
10.Yao JK, Reddy RD, van Kammen DP. Oxidative damage and schizophrenia: An overview of the evidence and its therapeutic implications. CNS Drugs 2001;15:287-310.  Back to cited text no. 10    
11.Mahadik SP, Mukherjee S. Free radical pathology and antioxidant defense in schizophrenia: A review. Schizophr Res 1996;19:1-17.  Back to cited text no. 11    
12.Rachkauskas GS. The level of lipid peroxidation and the function of the antioxidant system in different forms of schizophrenia. Lik Sprava 1998;5:92-3.  Back to cited text no. 12    
13.Bast A, Haenen GR, Doelman CJ. Oxidants and antioxidants: State of the art. Am J Med 1991;91:2S-13S.  Back to cited text no. 13    
14.Dadheech G, Mishra S, Gautam S, Sharma P. Oxidative stress and ascorbic acid status in schizophrenics. SFRR-Indian Bull 2005;4:23-5.  Back to cited text no. 14    
15.Dadheech G, Mishra S, Gautam S, Sharma P. Oxidative stress, α-tocopherol, ascorbic acid and reduced glutathione status in schizophrenics. Indian J Clin Biochem 2006;21:34-8.  Back to cited text no. 15    
16.Stock J, Dormandy TL. The autoxidation of human red cell lipids induced by hydrogen peroxide. Br J Hematol 1971;20:95-111.  Back to cited text no. 16    
17.Altuntas I, Aksoy H, Coskun I, Caykoylu A, Akcay F. Erythrocyte superoxide dismutase and glutathione peroxidase activities and malondialdehyde and reduced glutathione levels in schizophrenic patients. Clin Chem Lab Med 2000;38:1277-81.  Back to cited text no. 17    
18.Beutler E. Red cell metabolism. In : A manual of biochemical methods. Grune and Stration: New York; 1971. p. 103-5.  Back to cited text no. 18    
19.Fendri C, Mechri A, Khiari G, Othman A, Kerkeni A, Gaha L. Oxidative stress involvement in schizophrenia pathophysiology: A review. Encephale 2006;32:244-52.  Back to cited text no. 19    
20.Gutteridge JM, Halliwell B. Reoxygenation injury and antioxidant protection: A tale of two paradoxes. Arch Biochem Biophysics 1990;253:223-6.  Back to cited text no. 20    
21.Grima G, Benz B, Parpura V, Cuenod M, Do KQ. Dopamine-induced oxidative stress in neurons with glutathione deficit: Implication for schizophrenia. Schizophr Res 2003;62:213-24.  Back to cited text no. 21    
22.Knight JA. The biochemistry of aging. Adv Clin Chem 2000;35:1-62.  Back to cited text no. 22    
23.Ranjekar PK, Hinge A, Hegde MV, Ghate M, Kale V, Sitasawad S, et al . Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients. Psychiatr Res 2003;121:109-22.  Back to cited text no. 23    
24.Zhang XY, Tan YL, Cao LY, Wu GY, Xu Q, Shen Y, et al . Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics. Schizophr Res 2006;81:291-300.  Back to cited text no. 24    
25.Dakhale G, Khanzode S, Khanzode S, Saoji A, Khobragade L, Turankar A. Oxidative damage and schizophrenia: The potential benefit by atypical antipsychotics. Neuropsychobiology 2004;49:205-9.  Back to cited text no. 25    
26.Kuloglu M, Ustundag B, Atmaca M, Canatan H, Tezcan AE, Cinkiline N. Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder. Cell Biochem Funct 2002;20:171-5.  Back to cited text no. 26    
27.Rukmini MS, D'Souza B, D'Souza V. Superoxide dismutase and catalase activities and their correlation with malondialdehyde in schizophrenic patients. Indian J Clin Biochem 2004;19:114-8.  Back to cited text no. 27    

Correspondence Address:
Praveen Sharma
Department of Biochemistry, SMS Medical College, Jaipur
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0019-5545.39753

Rights and Permissions


  [Table - 1], [Table - 2], [Table - 3], [Table - 4], [Table - 5], [Table - 6], [Table - 7]

This article has been cited by
1 Active ribosomal genes, translational homeostasis and oxidative stress in the pathogenesis of schizophrenia and autism
Lev N. Porokhovnik,Vladimir P. Passekov,Nataliya L. Gorbachevskaya,Alexander B. Sorokin,Nataliya N. Veiko,Nataliya A. Lyapunova
Psychiatric Genetics. 2015; 25(2): 79
[Pubmed] | [DOI]
2 Omega-3 prevents behavior response and brain oxidative damage in the ketamine model of schizophrenia
A.I. Zugno,H.L. Chipindo,A.M. Volpato,J. Budni,A.V. Steckert,M.B. de Oliveira,A.S. Heylmann,F. da Rosa Silveira,G.A. Mastella,S.G. Maravai,P.G. Wessler,A.R. Binatti,B. Panizzutti,P.F. Schuck,J. Quevedo,C.S. Gama
Neuroscience. 2014; 259: 223
[Pubmed] | [DOI]
3 Oxidative stress, rRNA genes, and antioxidant enzymes in pathogenesis of schizophrenia and autism: Modeling and clinical recommendations
L. N. Porokhovnik,V. P. Pasekov,N. A. Yegolina,T. G. Tzvetkova,N. V. Kosyakova,N. L. Gorbachevskaya,N. K. Sukhotina,G. V. Kozlovskaya,A. B. Sorokin,N. Yu. Korovina,N. A. Lyapunova
Biology Bulletin Reviews. 2014; 4(5): 363
[Pubmed] | [DOI]
4 The Effects of Ziprasidone, Clozapine and Haloperidol on Lipid Peroxidation in Human Plasma (in vitro): Comparison
Anna Dietrich-Muszalska,Justyna Kopka,Anna Kwiatkowska
Neurochemical Research. 2013; 38(7): 1490
[Pubmed] | [DOI]
5 Vitamin C in Disease Prevention and Cure: An Overview
Shailja Chambial,Shailendra Dwivedi,Kamla Kant Shukla,Placheril J. John,Praveen Sharma
Indian Journal of Clinical Biochemistry. 2013; 28(4): 314
[Pubmed] | [DOI]
6 Reduced total antioxidant level and increased oxidative stress in patients with deficit schizophrenia: A preliminary study
Yakup Albayrak,Cüneyt Ünsal,Murat Beyazyüz,Ahmet Ünal,Murat Kuloglu
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2013; 45: 144
[Pubmed] | [DOI]
7 Changes in oxidative stress markers in patients with schizophrenia: The effect of antipsychotic drugs
Meng-Chang Tsai,Chia-Wei Liou,Tsu-Kung Lin,I-Mei Lin,Tiao-Lai Huang
Psychiatry Research. 2013; 209(3): 284
[Pubmed] | [DOI]
8 Meta-Analysis of Oxidative Stress in Schizophrenia
Joshua Flatow,Peter Buckley,Brian J. Miller
Biological Psychiatry. 2013; 74(6): 400
[Pubmed] | [DOI]
9 Possible pathophysiological mechanisms of changes in several cytokines and in the lipid peroxidation and antioxidant defense system in first-episode schizophrenia patients
N. V. Ozornina,A. S. Ozornin,N. V. Govorin
Neurochemical Journal. 2013; 7(3): 230
[Pubmed] | [DOI]
10 Sex differences in lipid peroxidation and fatty acid levels in recent onset schizophrenia
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2013; 44: 154
[VIEW] | [DOI]
11 Inter-relationship of plasma markers of oxidative stress and thyroid hormones in schizophrenics
Moses O Akiibinu, Omobola A Ogundahunsi, Ebenezer O Ogunyemi
BMC Research Notes. 2012; 5(1): 169
[VIEW] | [DOI]
12 Antioxidant defense system and family environment in adolescents with family history of psychosis
Ana Gonzalez-Pinto,Monica Martinez-Cengotitabengoa,Celso Arango,Immaculada Baeza,Soraya Otero-Cuesta,Montserrat Graell-Berna,César Soutullo,Juan Leza,Juan Micó
BMC Psychiatry. 2012; 12(1): 200
[Pubmed] | [DOI]
13 Oxidative Stress-Induced Response of Some Endogenous Antioxidants in Schizophrenia
Gora Dadheech, Praveen Sharma, Shiv Gautam
Indian Journal of Clinical Biochemistry. 2012;
[VIEW] | [DOI]
14 The reduction of superoxide dismutase activity is associated with the severity of neurological soft signs in patients with schizophrenia
Monia Raffa,Chiraz Fendri,Leila Ben Othmen,Héla Slama,Montassar Amri,Abdelhamid Kerkeni,Anwar Mechri
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2012; 39(1): 52
[Pubmed] | [DOI]
15 The Relationship Between Serum Uric Acid Concentration and Metabolic Syndrome in Patients With Schizophrenia or Schizoaffective Disorder
Chih-Chiang Chiu,Chun-Hsin Chen,Ming-Chyi Huang,Po-Yu Chen,Chang-Jer Tsai,Mong-Liang Lu
Journal of Clinical Psychopharmacology. 2012; 32(5): 585
[Pubmed] | [DOI]
16 Increased Oxidant Stress and Inflammation in Patients with Chronic Schizophrenia
Aysenur Yegin,Nurullah Ay,Ozgur Aydin,Nedim Yargici,Esin Eren,Necat Yilmaz
International Journal of Clinical Medicine. 2012; 03(05): 368
[Pubmed] | [DOI]
17 Viral infection, inflammation and schizophrenia
Rachel E. Kneeland, S. Hossein Fatemi
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2012;
[VIEW] | [DOI]
18 Oxidative stress in schizophrenia: An integrated approach
Byron K.Y. Bitanihirwe, Tsung-Ung W. Woo
Neuroscience & Biobehavioral Reviews. 2011; 35(3): 878
[VIEW] | [DOI]
19 Elevated plasma superoxide dismutase in first-episode and drug naive patients with schizophrenia: Inverse association with positive symptoms
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2011;
[VIEW] | [DOI]
20 Antioxidants, Redox Signaling, and Pathophysiology in Schizophrenia: An Integrative View
Jeffrey K. Yao, Matcheri S. Keshavan
Antioxidants and Redox Signaling. 2011; 15(7): 2011
[VIEW] | [DOI]
21 Evaluation of antioxidant enzymes activities and lipid peroxidation in schizophrenic patients treated with typical and atypical antipsychotics
Manuela Padurariu, Alin Ciobica, Irina Dobrin, Cristinel Stefanescu
Neuroscience Letters. 2010; 479(3): 317
[VIEW] | [DOI]
22 The implications of medication development in the treatment of substance use disorders in developing countries
Jagadisha Thirthalli, Prabhat K Chand
Current Opinion in Psychiatry. 2009; 22(3): 274
[VIEW] | [DOI]
23 Study of oxidative stress in obsessive compulsive disorder in response to treatment with Fluoxetine
Sutirtha Chakraborty, Anindya Dasgupta, Harendra Nath Das, Om Prakash Singh, Asok Kumar Mandal, Nikhiles Mandal
Indian Journal of Clinical Biochemistry. 2009; 24(2): 194
[VIEW] | [DOI]